Each letter in a logo is like a little ambassador for the brand: it murmurs (or sometimes shouts ... reflecting clearness and professionalism in communication. AstraZeneca – This pharmaceutical ...

AstraZeneca, as part of its ongoing $3.5 billion investment in American innovation, opened its first U.S.-operated cell therapy factory in Maryland to help treat cancer patients. The U.K-based ...

State officials and AstraZeneca marked the opening Monday of a cell therapy facility in Rockville that aims to create pathways to jobs for the state’s STEM professionals. AstraZeneca completed a ...

HEADQUARTERS IN ROCKVILLE. THIS LAB ISN’T OPEN OR OPERATIONAL YET, BUT ONCE IT IS, THE FOLKS AT ASTRAZENECA BELIEVE IT IS GOING TO REVOLUTIONIZE CANCER TREATMENT. IT GIVES US HOPE. I MEAN.

AstraZeneca recently announced its first-quarter earnings for 2025, showcasing strong financial performance with revenue rising to USD 13,588 million, up from the previous year. Despite this, the ...

Guidance AstraZeneca reiterates its Total Revenue and Core EPS guidance 5 for FY 2025 at CER, based on the average foreign exchange rates through 2024.

AstraZeneca to buy EsoBiotec for up to $1 billion Deal aims to enhance cancer cell therapy capabilities AstraZeneca secures global rights to Alteogen's ALT-B4 enzyme AstraZeneca shares up almost ...

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity. The ...

Over the past three years, additional insurance fraud cases have emerged involving AstraZeneca employees in various Chinese regions. Memorial Day Special: Access your full investing command center ...

Sharon Barr, executive vice-president of biopharmaceuticals R&D at AstraZeneca, delivers a speech at AstraZeneca R&D China Science Day held in Shanghai from Friday to Saturday. [Photo provided to ...

Sept 26 (Reuters) - AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune system to make certain cancer drug trials more ...